Prostate cancer PSMA PET scan access trial
Part of Cancer, Kidney & urinary clinical trials.
This study allows people with prostate cancer to get a special PET scan that finds cancer cells. The scan helps doctors plan the best treatment. You may qualify if your PSA is rising or you have high-risk prostate cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You can follow instructions and give permission (informed consent).
- You are able to lie still for about 30 minutes for the scan.
- You have a history of prostate cancer and meet one of these:
- Your PSA (prostate-specific antigen) is at a certain level after surgery, radiation, or other treatment.
- You have high-risk prostate cancer features like a high Gleason score or PSA over 20.
- You have a vein that can be used for the IV (intravenous) injection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study checks whether a PSMA PET/CT scan (using a special tracer) can help doctors make better decisions for people with prostate cancer after treatment, based on PSA blood test changes. It may help identify whether cancer has spread or how to plan next steps.
This trial tests if a special PET scan using PSMA-1007 can find prostate cancer spread in men who have just been diagnosed with high-risk prostate cancer and plan to have surgery. The scan may help doctors better understand the cancer before removing the prostate and lymph nodes.
This trial compares two types of PET/CT scans (using different radioactive tracers) to see which is better at finding prostate cancer, tracking its return, or spotting spread. It's for people with prostate cancer or those being checked for recurrence after treatment.
This trial uses a special PET/MR scan to help doctors aim stereotactic radiation more precisely for certain higher-risk or unfavorable intermediate prostate cancers. It studies whether this targeted approach can safely treat the prostate (and specific areas needing extra treatment) without spreading to the body.
This study uses a special type of PET scan called PSMA PET to better understand and track prostate cancer. The scan helps doctors see where the cancer is in the body and if treatment is working.
This study is looking at how well a special type of PET/CT scan (called PSMA PET/CT) can see cancer in people who have or may have certain tumors. It may help doctors better understand and track the disease.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.